Summary of HR 2810: Family Cord Blood Banking Act

Purpose and Intent

The Family Cord Blood Banking Act (HR 2810) aims to enhance the accessibility and utilization of cord blood banking for families across the United States. The bill seeks to promote the collection, preservation, and use of umbilical cord blood stem cells, which have significant potential in treating various medical conditions.

Key Provisions

The bill includes several important provisions designed to support families considering cord blood banking:

• Incentives for Families: The legislation proposes tax credits for families who choose to bank their newborn's cord blood. This financial incentive aims to alleviate the costs associated with private cord blood banking services.

• Public Awareness Campaigns: The bill mandates the establishment of educational programs to inform expectant parents about the benefits of cord blood banking, including its potential use in treating diseases such as leukemia and other blood disorders.

• Research Funding: HR 2810 allocates federal funds to support research initiatives focused on the therapeutic applications of cord blood stem cells. This funding is intended to advance scientific understanding and expand treatment options.

• Regulatory Framework: The bill calls for the development of a comprehensive regulatory framework to ensure the safety and efficacy of cord blood banking practices. This includes guidelines for collection, processing, and storage.

Affected Parties

The Family Cord Blood Banking Act would primarily affect:

• Expectant Families: Families considering cord blood banking will benefit from financial incentives and increased awareness of the options available to them.

• Healthcare Providers: Hospitals and healthcare professionals involved in childbirth will need to adapt to new guidelines and educational materials regarding cord blood collection.

• Research Institutions: Organizations engaged in stem cell research may receive additional funding to explore new treatments and applications for cord blood.

Procedural Aspects

• Introduced Date: The bill was introduced in the House on April 10, 2025.
• Committee Referral: Following its introduction, HR 2810 was referred to the House Committee on Ways and Means for further consideration.

Sponsors

The bill is sponsored by:
- Jodey C. Arrington (Primary Sponsor)
- Donald G. Davis (Cosponsor)
- Jimmy Panetta (Cosponsor)

Conclusion

The Family Cord Blood Banking Act represents a significant step towards increasing the accessibility and understanding of cord blood banking for families. By providing financial incentives, promoting education, and supporting research, the bill aims to enhance the potential benefits of cord blood stem cells in medical treatments. As it progresses through the legislative process, stakeholders will be closely monitoring its developments and potential impacts on public health.